Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P. Bhatt, Raolat M. Abdulai, Stephanie A. Christenson et al.|New England Journal of Medicine|2023Cited by 452
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 InflammationSurya P. Bhatt, Lacey B. Robinson, Klaus F. Rabe et al.|New England Journal of Medicine|2024Cited by 240
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitisAyodeji Adegunsoye, Rekha Vij, Justin M. Oldham et al.|ERJ Open Research|2017Cited by 125